HMA Life Sciences consulting guides innovators through a complex market.

HMA Life Sciences consulting guides innovators through a complex market — and on to success.

Life Sciences organizations and their innovative research are crucial to the advancement of healthcare, in the U.S. and globally. And it takes more than scientific knowledge for biotech, med-tech, therapeutics, diagnostics, medical software and other Life Sciences companies to succeed. It takes a deep, comprehensive knowledge of the healthcare industry, its markets, and the regulatory and statutory policies that affect it.

That’s where HMA’s team of expert Life Sciences consultants can make all the difference. HMA has in-depth, practical knowledge of the complex challenges you face. And we’re ready to help you solve them.

Our Services: How we make life easier for Life Sciences companies.

We provide a broad spectrum of services for stakeholders in the Life Sciences industry.

FDA regulatory strategy. Product development, marketing authorization strategies, and regulatory guidance throughout the product life cycle.

Commercial strategy. Market intelligence, strategic planning, business development, formulary and market access insights, and go-to-market/launch strategies.

Reimbursement strategy for Medicaid, Medicare and commercial markets. Guidance for coding, coverage, and payment pathways for approved products and services, including coding applications and payer education; strategies to support product access and value, including replication of Medicare payment systems.

Federal policy. Creation and advancement of federal policy and strategies to overcome your organization’s challenges; assessment of upstream and downstream impacts of an evolving policy landscape; modeling impacts of CMS payment changes; identification of new Medicare program reimbursement opportunities under value-based care.

State policy. Navigation of state policy landscape, strategy development for product access and value in Medicaid programs, and state research support.

Investment strategy. Due diligence studies, research projects, billing and compliance reviews, and analysis of federal, state, and local reimbursement/regulatory issues.

Health services research and actuarial services. Analysis of Medicare and Medicaid (T-MSIS) and commercial payer data, health economic outcomes, patient population, trends in products and services, health plan enrollment data, financials, quality data and more to inform policy and strategy development.

Public affairs. Strategic communications, media planning, public relations, stakeholder engagement, corporate communications, and digital marketing strategy, including data analytics and SEO optimization.

Comprehensive expertise for every stage of your journey.

Innovative Life Sciences companies have a broad range of needs — and HMA has the breadth of expertise to match. Our consultants are experts in federal and state policy, reimbursement strategy, actuarial consulting, medical coding support, public affairs, investment strategy, and corporate development. From early steps of research and development to product-specific communications to commercial and reimbursement strategies, we can guide you at every stage. And our in-depth knowledge of the current political dynamics and regulatory environment can help you navigate obstacles and get your products to the patients who can benefit most.

Meet the team ready to solve your organization’s complex challenges.

The HMA team offers specific Life Sciences experience, deep knowledge of the overall healthcare industry, and unique expertise at the intersection of these two worlds. Before joining HMA, our consultants spent years as senior officials in Medicare and Medicaid, cabinet-level health secretaries, government policy advisers, and directors of large nonprofit and social services organizations.